Atogepant for preventing migraine [ID5090]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 15 May 2024
Migraine trigger site deactivation surgeryStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Kinetic Oscillation Stimulation to the nasal cavity for the preventive treatment of adults diagnosed with chronic migraineStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
CT guided fibrin glue sealing of CSf leak to treat spontaneous intracranial hypotensionStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Botulinum toxin type A for preventing episodic migraine TS ID 11939Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Zavegepant for treating acute migraine TSID 11998Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC